MLTX (MoonLake Immunotherapeutics) Other Current Receivables: $5.76 Mil (As of Mar. 2026)


MLTX MoonLake Immunotherapeutics MLTX
31 GF Score
Price $18.95
! 3 Warning Signs
View Full Analysis

What is MoonLake Immunotherapeutics Other Current Receivables?

MoonLake Immunotherapeutics MLTX -0.92% 31 Other Current Receivables is $5.76 Mil as of Mar. 2026. GuruFocus rates MLTX with a GF Score™ of 31/100. The stock has 3 warning signs investors should review.

MoonLake Immunotherapeutics's Other Current Receivables for the quarter that ended in Mar. 2026 was $5.76 Mil.

MoonLake Immunotherapeutics's quarterly Other Current Receivables increased from Sep. 2025 ($4.02 Mil) to Dec. 2025 ($4.87 Mil) and increased from Dec. 2025 ($4.87 Mil) to Mar. 2026 ($5.76 Mil).

MoonLake Immunotherapeutics's annual Other Current Receivables increased from Dec. 2023 ($1.06 Mil) to Dec. 2024 ($2.84 Mil) and increased from Dec. 2024 ($2.84 Mil) to Dec. 2025 ($4.87 Mil).

MoonLake Immunotherapeutics Other Current Receivables Related Terms

MoonLake Immunotherapeutics Other Current Receivables Historical Data

* Premium members only.

The historical data trend for MoonLake Immunotherapeutics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MoonLake Immunotherapeutics Other Current Receivables Chart

MoonLake Immunotherapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
0.15 0.22 1.06 2.84 4.87

MoonLake Immunotherapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.99 3.41 4.02 4.87 5.76
MLTX
31GF Score
MoonLake Immunotherapeutics MLTX
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MoonLake Immunotherapeutics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $5.76 Mil mean?
MoonLake Immunotherapeutics (MLTX) has a Other Current Receivables of $5.76 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on MoonLake Immunotherapeutics and its competitors.
Is MoonLake Immunotherapeutics' Other Current Receivables too high?
MoonLake Immunotherapeutics' current Other Current Receivables is $5.76 Mil. Overall, MoonLake Immunotherapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does MoonLake Immunotherapeutics' Other Current Receivables compare to FTRE and SEPN?
MoonLake Immunotherapeutics' Other Current Receivables of $5.76 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on MoonLake Immunotherapeutics and its competitors. MoonLake Immunotherapeutics's current Other Current Receivables is $5.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MoonLake Immunotherapeutics stock overvalued right now?
MoonLake Immunotherapeutics (MLTX) has a current Other Current Receivables of $5.76 Mil. The current Other Current Receivables is $5.76 Mil. MoonLake Immunotherapeutics' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For MoonLake Immunotherapeutics (MLTX), the current Other Current Receivables is $5.76 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MoonLake Immunotherapeutics Business Description

Address Dorfstrasse 29, Zug, CHE, 6300
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
31GF Score

Get the complete analysis for MLTX

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.95
Price